行动证据:应对抗菌药物耐药性的同一健康学习平台
该文指出抗菌药物耐药性干预措施数量增加,但现有研究在力度、方法、范围、质量和报告方面存在重大局限。作者主张在加强全球治理框架下创建国际同一健康在线学习平台,整合干预证据数据库,生成设计、实施、评价与报告的新科学见解,以构建社会韧性。
要点
- 抗菌药物耐药性干预研究在方法、范围、质量和报告上存在重大局限
- 需理解干预措施的多样性、可行性、成本效益及实施影响因素
- 倡导创建国际同一健康在线学习平台以整合证据并生成新见解
核心结论
- 为应对抗菌药物耐药性,需要改善行动证据并创建国际同一健康在线学习平台。
研究设计与样本
- 原文为Lancet Infect Dis发表的论述性文章,非系统研究,未报告样本量。
主要发现
- 抗菌药物耐药性干预措施数量在增加,但当前研究在力度、方法、范围、质量和报告方面存在重大局限。
- 需要更好理解干预措施的多样性、可行性、成本效益及影响其有效性的实施因素。
- 不同干预措施可能在不同背景下产生协同或拮抗作用,影响抗菌药物耐药性行动。
关键数值与推荐
- 倡导创建国际同一健康在线学习平台,将抗菌药物耐药性行动证据整合为完全可访问的数据库。
- 平台应生成关于广泛干预措施设计、实施、评价和报告的新科学见解。
临床怎么用
- 临床及感染防控人员可关注该平台以获取抗菌药物耐药性干预措施的综合证据。
- 在设计和实施抗菌药物耐药性干预时,需考虑可行性、成本效益及实施影响因素。
局限性
- 原文为论述性文章,未报告系统检索范围、样本量或定量研究数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Improving evidence for action is crucial to tackle antimicrobial resistance. The number of interventions for antimicrobial resistance is increasing but current research has major limitations in terms of efforts, methods, scope, quality, and reporting. Moving the agenda forwards requires an improved understanding of the diversity of interventions, their feasibility and cost-benefit, the implementation factors that shape and underpin their effectiveness, and the ways in which individual interventions might interact synergistically or antagonistically to influence actions against antimicrobial resistance in different contexts. Within the efforts to strengthen the global governance of antimicrobial resistance, we advocate for the creation of an international One Health platform for online learning. The platform will synthesise the evidence for actions on antimicrobial resistance into a fully accessible database; generate new scientific insights into the design, implementation, evaluation, and reporting of the broad range of interventions relevant to addressing antimicrobial resistance; and ultimately contribute to the goal of building societal resilience to this central challenge of the 21st century.
引用
- Wernli D, Jørgensen PS, Parmley EJ, et al. Evidence for action: a One Health learning platform on interventions to tackle antimicrobial resistance. Lancet Infect Dis. 2020. PMID: 32853549. doi:10.1016/S1473-3099(20)30392-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。